SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-100990
Filing Date
2024-08-27
Accepted
2024-08-27 16:01:20
Documents
80
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K ocs-20240630.htm   iXBRL 6-K 129874
2 EX-99.1 ocs-ex99_1.htm   iXBRL EX-99.1 1766569
3 EX-99.2 ocs-ex99_2.htm EX-99.2 529684
4 EX-99.3 ocs-ex99_3.htm EX-99.3 204348
5 EX-99.4 ocs-ex99_4.pdf EX-99.4 878804
6 EX-99.5 ocs-ex99_5.pdf EX-99.5 627478
7 GRAPHIC img187686630_0.jpg GRAPHIC 11150
8 GRAPHIC img189533672_0.jpg GRAPHIC 8129
  Complete submission text file 0000950170-24-100990.txt   12616040

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ocs-20240630.xsd EX-101.SCH 1184205
83 EXTRACTED XBRL INSTANCE DOCUMENT ocs-20240630_htm.xml XML 1611703
Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Filer) CIK: 0001953530 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41636 | Film No.: 241248925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)